#11: Pulmonary Disease States 3 Flashcards
etiologies of bronchiectasis: (7)
1- Infx (Klebsiella, MAC, mycoplasma, Staph, TB)
2- Bronchial obstruction (tumor, FB, stenosis)
3- Aspiration
4- CF and Young Syndrome
5- allergic bronchopulmonary aspergillus
6- AAT deficiency
7- Autoimmune/CT disorders (rare causes: anatomic abnormality, primary ciliary dyskinesia, congenital immune dysfx)
MC epidemiology of bronchiectasis:
- > 60 y.o.
- caucasian
- females
- thin/slender
- MC primary dz w/ MAC (Lady Windermere dz)
Pathophysiology associated w/ Bronchiectasis: (3)
1- permanent dilation of the proximal and medium sized bronchi (due to destruction of bronchial walls)
2- progressive inability to clear secretions and resolve colonization or repeated infx
3- Chronic airway obstructive dz
SXS of bronchiectasis: (8)
1- cough (common w/ hemoptysis) 2- dyspnea 3- daily muculopurulent sputum 4- fever 5- pleuritic CP 6- wheezing 7- weight loss 8- weakness
Imaging of choice in bronchiectasis:
HRCT with contrast
Mainstay tx modalities for bronchiectasis for sxs tx:
abx and chest physiotherapy
- others may include bronchodilators, corticosteroids, diertary supplementation, oxygen and surgery
Bronchiectasis defined as exacerbation and tx:
- increased and more viscous sputum with foul odor
- hospital admission, IV abx and supplemental nutrition
surfactant production in the fetus begins at:
32-34 wks
surfactant production becomes sufficient at:
34-36 wks
Type 2 alveolar cell growth begins at:
20 wks
Fetal lung maturation can be assessed via:
testing amniotic fluid for lecithin levels
What would decrease surfactant levels: (5)
1- hypovolemia 2- hypothermia 3- hypoxemia 4- acidosis 5- rare genetic disorders
RDS risk factors: (9)
1- *MC: prematurity (1/3 between 28-32 wks) 2- asphyxia 3- CS w/o labor 4- caucasian 5- fetal distress 6- male 7- maternal DM 8- previous premie w/ RDS 9- 2nd of twins